A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Mesothelioma (Pegathor Lung 202)
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Phase I Trial of Atezolizumab and Interleukin-12 Gene Therapy in Metastatic Non-Small Cell Lung Cancer With Progression on First-Line Immunotherapy With or Without Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE1
Observational Study of Afatinib 30 mg Daily
- Status
- RECRUITING
- Phase
- N/A
A Study of Canakinumab With Chemotherapy, Radiation Therapy, and Durvalumab in People With Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Trial of AK112 (PD-1/VEGF Bispecific Antibody) in Patients With NSCLC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
EF-36/Keynote B36: A Pilot, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Pembrolizumab for First Line Treatment of Advanced or Metastatic Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study of Inlexisertib (DCC-3116) in Participants With RAS/MAPK Pathway Mutant Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer
- Status
- WITHDRAWN
- Phase
- N/A
Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Immune and Genomic Markers in ALK+ NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Study to Test the Safety and Tolerability of PF-07257876 in Participants With Selected Advanced Tumors.
- Status
- COMPLETED
- Phase
- PHASE1
NAP in Combination With Docetaxel Following Obinutuzumab Pretreatment in Subjects With Checkpoint Inhibitor Pretreated Advanced or Metastatic NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Energy for Lymphocytes
- Status
- COMPLETED
- Phase
- N/A
Testing the Addition of Activity Monitoring With a Wearable Electronic Device to Improve Patient Care During Treatment for Lung Cancer
- Status
- TERMINATED
- Phase
- NA
SBRT/LDRT in Combination With Camrelizumab and Apatinib in Metastatic Non-small Cell Lung Cancer Patient Previously Treated With PD-1/L1 Inhibitor and Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE2
A Safety and Tolerability Study of NC762 in Subjects With Advanced or Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2